IIM
ALNY icon

INTECH Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

INTECH Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
36,760
-31,249
-46% -$9.43M 0.1% 169
2026
Q1 		$22.5M Buy
68,009
+21,299
+46% +$7.25M 0.22% 76
2025
Q4 		$18.6M Buy
46,710
+40,898
+704% +$18.1M 0.17% 98
2025
Q3 		$2.65M Buy
5,812
+1,404
+32% +$572K 0.02% 627
2025
Q2 		$1.44M Sell
4,408
-1,490
-25% -$412K 0.01% 982
2025
Q1 		$1.59M Sell
5,898
-1,675
-22% -$430K 0.02% 896
2024
Q4 		$1.78M Buy
7,573
+428
+6% +$113K 0.02% 778
2024
Q3 		$1.97M Hold
7,145
– – 0.02% 490
2024
Q2 		$1.74M Sell
7,145
-3,740
-34% -$590K 0.02% 481
2024
Q1 		$1.63M Buy
10,885
+3,344
+44% +$558K 0.02% 394
2023
Q4 		$1.44M Sell
7,541
-3,689
-33% -$628K 0.02% 380
2023
Q3 		$1.99M Buy
11,230
+2,864
+34% +$546K 0.03% 350
2023
Q2 		$1.59M Sell
8,366
-28,799
-77% -$5.71M 0.02% 398
2023
Q1 		$7.44M Buy
37,165
+11,093
+43% +$2.33M 0.06% 323
2022
Q4 		$6.2M Buy
26,072
+10,149
+64% +$2.16M 0.05% 351
2022
Q3 		$3.19M Buy
15,923
+8,587
+117% +$1.64M 0.02% 398
2022
Q2 		$1.07M Buy
+7,336
New +$1.04M 0.01% 518

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's ALNY Position: Q2 2026 in Review

INTECH Investment Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 46% in Q2 2026, selling an estimated $9.43M and leaving 36,760 shares worth $11.1M. The position accounts for 0.1% of the portfolio, ranked #169.

INTECH Investment Management first reported a position in ALNY in Q2 2022 and has held it in 17 quarters since. The position peaked at $22.5M in Q1 2026. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • INTECH Investment Management held 36,760 shares of Alnylam Pharmaceuticals worth $11.1M as of Q2 2026.
  • INTECH Investment Management sold 31,249 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $9.43M.
  • Alnylam Pharmaceuticals made up 0.1% of INTECH Investment Management's portfolio in Q2 2026, its #169 holding.
  • INTECH Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's Alnylam Pharmaceuticals position peaked at $22.5M in Q1 2026.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.